Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medigus (MDGS)
NASDAQ:MDGS
Medigus (MDGS) Stock Price & Analysis
221 Followers
MDGS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.11 - $7.17
Previous Close$2.45
Volume28.87K
Average Volume (3M)11.16K
Market Cap
$4.17M
Enterprise Value-$12.09M
Total Cash (Recent Filing)$33.00M
Total Debt (Recent Filing)$1.19M
Price to Earnings (P/E)-0.3
Beta0.28
Next Earnings
May 01, 2024EPS EstimateN/A
Last Dividend Ex-Date
Dec 19, 2022Dividend Yield32.65%
Share Statistics
EPS (TTM)-8.90
Shares Outstanding1,644,098
10 Day Avg. Volume19,406
30 Day Avg. Volume11,164
Standard Deviation0.24
R-Squared0.08
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.73
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Medigus News
PremiumCompany Announcements
Xylo Technologies Ltd. Confronts Shareholder Lawsuit
PremiumCompany Announcements
Medigus Ltd. Rebrands as Xylo Technologies
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.12% Other Institutional Investors
99.85% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDGS FAQ
What was Medigus’s price range in the past 12 months?
Medigus lowest stock price was $2.11 and its highest was $7.17 in the past 12 months.
What is Medigus’s market cap?
Currently, no data Available
When is Medigus’s upcoming earnings report date?
Medigus’s upcoming earnings report date is May 01, 2024 which is in 5 days.
How were Medigus’s earnings last quarter?
Medigus released its earnings results on Sep 28, 2023. The company reported -$5.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$5.022.
Is Medigus overvalued?
According to Wall Street analysts Medigus’s price is currently Overvalued.
Does Medigus pay dividends?
Medigus pays a Notavailable dividend of $0.8 which represents an annual dividend yield of 32.65%. See more information on Medigus dividends here
What is Medigus’s EPS estimate?
Medigus’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medigus have?
Medigus has 1,701,638 shares outstanding.
What happened to Medigus’s price movement after its last earnings report?
Medigus reported an EPS of -$5.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.737%.
Which hedge fund is a major shareholder of Medigus?
Currently, no hedge funds are holding shares in MDGS
---
Medigus Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Medigus
Medigus Ltd. is a medical device company, which engages in the research and development, manufacture, and sale of endosurgical tools and instruments. It specializes in the area of Gastroesophageal reflux disease. Its product MUSE System offers minimal invasive endoscopic devices and procedures for gastric surgery. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel.
---
Technical Analysis
---